BioCryst Pharmaceuticals
BCRX
#5060
Rank
โ‚น143.74 B
Marketcap
โ‚น682.72
Share price
-0.52%
Change (1 day)
4.09%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚น40.10 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total assets are โ‚น40.10 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BioCryst Pharmaceuticals - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚น42.07 B-2.24%
2023-12-31โ‚น43.03 B-5.44%
2022-12-31โ‚น45.51 B3.96%
2021-12-31โ‚น43.77 B78.83%
2020-12-31โ‚น24.47 B95.84%
2019-12-31โ‚น12.49 B21.74%
2018-12-31โ‚น10.26 B-9.79%
2017-12-31โ‚น11.38 B86.42%
2016-12-31โ‚น6.10 B-24.91%
2015-12-31โ‚น8.13 B-6.26%
2014-12-31โ‚น8.67 B187.35%
2013-12-31โ‚น3.01 B-4.01%
2012-12-31โ‚น3.14 B-27.68%
2011-12-31โ‚น4.34 B-11.33%
2010-12-31โ‚น4.90 B-25.67%
2009-12-31โ‚น6.59 B62.08%
2008-12-31โ‚น4.07 B-27.32%
2007-12-31โ‚น5.60 B84.65%
2006-12-31โ‚น3.03 B-32.08%
2005-12-31โ‚น4.46 B217.62%
2004-12-31โ‚น1.40 B2.62%
2003-12-31โ‚น1.37 B-30.81%
2002-12-31โ‚น1.98 B-30.54%
2001-12-31โ‚น2.85 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Repligen
RGEN
โ‚น262.63 B 554.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น313.81 B 682.54%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
โ‚น0.79 B-98.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น105.99 B 164.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น5.258 T 13,011.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น58.24 B 45.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น7.407 T 18,371.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
โ‚น131.24 B 227.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
โ‚น1.82 B-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA